Results 121 to 130 of about 8,184 (177)
Assessment of scabies diagnosis and the impact of MDA for onchocerciasis on the burden of scabies in an endemic community in Ghana. [PDF]
Osei-Mensah J +10 more
europepmc +1 more source
Significant gap between Point participation and long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis transmission focus, Wenchi, Ghana. [PDF]
Nditanchou R +15 more
europepmc +1 more source
The risk of onchocerciasis infection by human population movements between high and low transmission settings in Ghana. [PDF]
Pi-Bansa S +12 more
europepmc +1 more source
Human Filariasis in Africa (2000-2025): Changing epidemiology, uneven diagnostic progress, and persistent neglect. [PDF]
Wilczyńska W +2 more
europepmc +1 more source
Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review. [PDF]
Lotola Mougeni F +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Infectious Disease Clinics of North America, 1992
Onchocerciasis is a parasitic disease with blinding consequences infecting approximately 18 million persons worldwide. In hyperendemic areas, nearly half the population are likely to become blind before they die. Blindness reduces the life expectancy of those affected and has an enormous socioeconomic impact on these communities. Ivermectin, given as a
A E, Malatt, H R, Taylor
openaire +2 more sources
Onchocerciasis is a parasitic disease with blinding consequences infecting approximately 18 million persons worldwide. In hyperendemic areas, nearly half the population are likely to become blind before they die. Blindness reduces the life expectancy of those affected and has an enormous socioeconomic impact on these communities. Ivermectin, given as a
A E, Malatt, H R, Taylor
openaire +2 more sources
International Ophthalmology, 1990
Onchocerciasis is a devastating blinding disease caused by the parasite Onchocerca volvulus that infects about 80 million people, causing blindness and visual impairment in 1-2 million people. In hyperendemic areas, more than half of the population will become blind from onchocerciasis before they die.
openaire +4 more sources
Onchocerciasis is a devastating blinding disease caused by the parasite Onchocerca volvulus that infects about 80 million people, causing blindness and visual impairment in 1-2 million people. In hyperendemic areas, more than half of the population will become blind from onchocerciasis before they die.
openaire +4 more sources
Drugs, 1996
Onchocerciasis ('river blindness') has for several centuries been the scourge of people living in certain areas of the world where the disease is endemic. The treatment available up to 10 years ago, diethylcarbamazine, had very severe secondary effects.
Y, Van Laethem, C, Lopes
openaire +2 more sources
Onchocerciasis ('river blindness') has for several centuries been the scourge of people living in certain areas of the world where the disease is endemic. The treatment available up to 10 years ago, diethylcarbamazine, had very severe secondary effects.
Y, Van Laethem, C, Lopes
openaire +2 more sources
Gynaecomastia in onchocerciasis
The Lancet, 1997Many clinical manifestations of onchocerciasis have been described, but we have not seen any reports of gynaecomastia. We are involved in a field study looking at the impact of ivermectin on oncho-dermatitis in hyperendemic communities, and found gynaecomastia in 63 of 301 men examined before being given ivermectin (figure).
D O, Okello +2 more
openaire +2 more sources
2006
Onchocerciasis is a filarial infection which causes blindness and debilitating skin lesions. The disease occurs in 37 countries, of which 30 are found in Africa (the most affected in terms of the distribution and the severity of the clinical manifestations of the disease), six in the Americas and one in the Arabian Peninsula.
Boakye A, Boatin, Frank O, Richards
openaire +2 more sources
Onchocerciasis is a filarial infection which causes blindness and debilitating skin lesions. The disease occurs in 37 countries, of which 30 are found in Africa (the most affected in terms of the distribution and the severity of the clinical manifestations of the disease), six in the Americas and one in the Arabian Peninsula.
Boakye A, Boatin, Frank O, Richards
openaire +2 more sources

